Phreesia (PHR) reported $106.8 million in income for the quarter ended October 2024, representing a year-over-year improve of 16.6%. EPS of -$0.25 for a similar interval compares to -$0.58 a yr in the past.
The reported income compares to the Zacks Consensus Estimate of $106 million, representing a shock of +0.76%. The corporate delivered an EPS shock of +13.79%, with the consensus EPS estimate being -$0.29.
Whereas traders scrutinize income and earnings adjustments year-over-year and the way they evaluate with Wall Road expectations to find out their subsequent transfer, some key metrics at all times supply a extra correct image of an organization’s monetary well being.
Since these metrics play a vital function in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps traders higher undertaking a inventory’s value efficiency.
Right here is how Phreesia carried out within the simply reported quarter when it comes to the metrics most generally monitored and projected by Wall Road analysts:
- Common healthcare providers Shoppers: 4,237 versus the three-analyst common estimate of 4,251.
- Common income per healthcare providers consumer: $17.48 million versus the three-analyst common estimate of $17.75 million.
- Affected person fee quantity: $1.08 billion versus the three-analyst common estimate of $1.10 billion.
- Cost facilitator quantity share: 81% versus 81.5% estimated by two analysts on common.
- Revenus- Subscription and associated providers: $49.36 million in comparison with the $50.36 million common estimate based mostly on six analysts. The reported quantity represents a change of +15.9% yr over yr.
- Revenus- Community options: $32.73 million versus the six-analyst common estimate of $30.93 million. The reported quantity represents a year-over-year change of +26.8%.
- Revenus- Cost processing charges: $24.70 million versus $25.06 million estimated by six analysts on common. In comparison with the year-ago quarter, this quantity represents a +6.4% change.
View all Key Company Metrics for Phreesia here>>>
Shares of Phreesia have returned +2.3% over the previous month versus the Zacks S&P 500 composite’s +2.9% change. The inventory at the moment has a Zacks Rank #3 (Maintain), indicating that it might carry out consistent with the broader market within the close to time period.
Free As we speak: Making the most of The Future’s Brightest Vitality Supply
The demand for electrical energy is rising exponentially. On the similar time, we’re working to cut back our dependence on fossil fuels like oil and pure gasoline. Nuclear power is a perfect alternative.
Leaders from the US and 21 different nations just lately dedicated to TRIPLING the world’s nuclear power capacities. This aggressive transition might imply super income for nuclear-related shares – and traders who get in on the motion early sufficient.
Our pressing report, Atomic Alternative: Nuclear Vitality’s Comeback, explores the important thing gamers and applied sciences driving this chance, together with 3 standout shares poised to learn probably the most.
Download Atomic Opportunity: Nuclear Energy’s Comeback free today.
Phreesia, Inc. (PHR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
